Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease

Phytotherapy Research

Volumn 14, Issue 7, 2000, Pages 510-516

  Hussein, Ghazi ^a   Miyashiro, Hirotsugu ^a   Nakamura, Norio ^a   Hattori, Masao ^a   Kakiuchi, Nobuko ^b   Shimotohno, Kunitada ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Embelia schimperi; Embelin; HCV protease; Sudanese medicinal plants

Indexed keywords

5 O METHYLEMBELIN; ACACIA NILOTICA EXTRACT; BENZOQUINONE DERIVATIVE; BOSWELLIA CARTERII EXTRACT; EMBELIN; EMBELLIA SCHIMPERI EXTRACT; PIPER CUBEBA EXTRACT; PROTEINASE INHIBITOR; QUERCUS INFECTORIA EXTRACT; SERINE PROTEINASE INHIBITOR; TRACHYSPERMUM AMMI EXTRACT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HEPATITIS C VIRUS; IC 50; MEDICINAL PLANT; NONHUMAN; PHYTOTHERAPY; SUDAN; TRADITIONAL MEDICINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOPEPTIDASES; HEPACIVIRUS; HEPATITIS C; HUMANS; MEDICINE, TRADITIONAL; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTEASE INHIBITORS; SUDAN;

ACACIA NILOTICA; AMMI; BOSWELLIA; EMBELIA; EMBELIA SCHIMPERI; HEPATITIS C VIRUS; PIPER CUBEBA; QUERCUS INFECTORIA; SYZYGIUM AROMATICUM; TRACHYSPERMUM AMMI;

EID: 0033758416     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B     Document Type: Article

References (28)

1. The long term efficacy of glycyrrhizin in chronic hepatitis C patients
2. Molecular targets in inhibition of hepatitis C virus replication
3. Anthelmintic usage of extracts of Embelia schimperi from Tanzania
4. Caffeoyl conjugates from Echinacea species: Structures and biological activity
5. Antitumor, anti-inflammatory and analgesic property of embelin, a plant product
6. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome
7. Structure of Sch 68631: A new hepatitis C virus proteinase inhibitor from Streptomyces sp
8. Reversible contraception like activity of embelin in male dogs (Canis indicus Linn)
9. (-)-Quinic acid: Configurational (stereochemical) descriptors
10. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus non-structural proteins
11. 1H NMR investigations of quinic acid derivatives: Complete spectral assignment and elucidation of preferred conformations
12. Benzoquinone derivatives. Part I. Reactions of primary aliphatic amines with embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone) and di-O-methylembelin
13. Non-peptide inhibitors of HCV serine proteinase
14. Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate
15. The phenolic acids of Lithospermum ruderale II. Carbon-13 nuclear magnetic resonance of lithospermic and rosmarinic acids
16. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR
17. The hepatitis C virus NS3 serine protease and co-factor: Establishment of a cell-free transprocessing assay
18. The molecular virology of hepatitis C
19. A flavonol glycoside from Embelia schimperi leaves
20. Biembelin - A new symmetrical bisbenzoquinone from Rapanea melanphloes
21. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)
22. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
23. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro
24. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography
25. Novel hepatitis C virus protease inhibitors: Thiazolidine derivatives
26. Novel hepatitis C virus protease inhibitors: 2, 4, 6-trihydroxy, 3-nitrobenzamide derivatives
27. Hepatitis C: Global prevalence